Elite Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Elite Pharmaceuticals, Inc. (ELTP) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum of 81.00% for the 12-month period ending 2024-03-31, per its 10-K filed 2025-06-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum · last filed 2025-06-30
- Elite Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2018-06-30 was 123.00%, a 1.15% increase year-over-year.
- Elite Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2017-06-30 was 121.60%.
- Elite Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2024 was 81.00%, a 1.25% increase from fiscal 2023.
- Elite Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2023 was 80.00%.
- Elite Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2018 was 123.00%, a 1.65% increase from fiscal 2017.
- Elite Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2017 was 121.00%, a 0.83% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 12 month |
|---|---|---|---|---|
| 2024-03-31 | 81.00% 10-K · filed 2025-06-30 | |||
| 2023-12-31 | 81.00% 10-Q · filed 2024-02-14 | |||
| 2023-03-31 | 80.00% 10-K · filed 2024-07-01 | |||
| 2018-06-30 | 123.00% 10-Q · filed 2018-08-09 | |||
| 2018-03-31 | 123.00% 10-K · filed 2019-06-21 | |||
| 2017-12-31 | 123.00% 10-Q · filed 2018-02-09 | |||
| 2017-09-30 | 123.20% 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | 121.60% 10-Q · filed 2017-08-09 | |||
| 2017-03-31 | 121.00% 10-K · filed 2018-06-14 | |||
| 2016-12-31 | 121.00% 10-Q · filed 2017-02-09 | |||
| 2016-09-30 | 121.00% 10-Q · filed 2016-11-09 | |||
| 2016-03-31 | 120.00% 10-K · filed 2018-06-14 | |||
| 2015-03-31 | 121.00% 10-K · filed 2017-06-14 |